Back
Cytokinetics Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
42
CYTK
Cytokinetics
Last Price:
51.37
Seasonality Move:
10.01%
Sell
41
ALNY
Alnylam Pharmaceuticals
Last Price:
281.58
Seasonality Move:
13.96%
Sell
42
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $51.51. The Score for CYTK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $284.69. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $51.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $284.69
The current trend is moderately bearish and ALNY is experiencing slight buying pressure.
CYTK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 40.31 | Sell |
Chaikin Money Flow: | -241160 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.28 - 55.12) | Sell |
Bollinger Bands (100): | (52.99 - 56.93) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.22 | Buy |
Relative Strength Index (14 RSI): | 52.21 | Buy |
Chaikin Money Flow: | 18297 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (270.92 - 291.12) | Buy |
Bollinger Bands (100): | (215.05 - 289.81) | Buy |
CYTK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.03 | Sell |
20-day SMA: | 53.96 | Sell |
50-day SMA: | 54.65 | Sell |
200-day SMA: | 62.09 | Sell |
8-day EMA: | 52.73 | Sell |
20-day EMA: | 53.56 | Sell |
50-day EMA: | 54.42 | Sell |
200-day EMA: | 55.79 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 291.18 | Sell |
20-day SMA: | 282.87 | Buy |
50-day SMA: | 274.65 | Buy |
200-day SMA: | 204.43 | Buy |
8-day EMA: | 288.3 | Sell |
20-day EMA: | 284.33 | Buy |
50-day EMA: | 272.82 | Buy |
200-day EMA: | 225.29 | Buy |
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.77 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.32 per share, and an increase next year of $0.75 per share.
Cytokinetics Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |